• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomycin determined by agar dilution and disk diffusion methods.琼脂稀释法和纸片扩散法测定常见细菌分离株对磷霉素的药敏性。
Antimicrob Agents Chemother. 2011 Sep;55(9):4295-301. doi: 10.1128/AAC.00349-11. Epub 2011 Jun 13.
2
Susceptibility of multiresistant gram-negative bacteria to fosfomycin and performance of different susceptibility testing methods.多重耐药革兰氏阴性菌对磷霉素的敏感性及不同药敏试验方法的性能
Antimicrob Agents Chemother. 2014;58(3):1763-7. doi: 10.1128/AAC.02048-13. Epub 2013 Dec 9.
3
Bacterial susceptibility in bloodstream infections: Results from China Antimicrobial Resistance Surveillance Trial (CARST) Program, 2015-2016.血流感染中的细菌药敏性:中国抗菌药物耐药监测研究(CARST)项目,2015-2016 年结果。
J Glob Antimicrob Resist. 2019 Jun;17:276-282. doi: 10.1016/j.jgar.2018.12.016. Epub 2019 Jan 3.
4
Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.美国革兰氏阴性菌和革兰氏阳性菌的抗菌药敏率最新情况:2005年至2007年替加环素评估与监测试验(TEST)结果
Clin Ther. 2008 Nov;30(11):2040-50. doi: 10.1016/j.clinthera.2008.11.006.
5
Fosfomycin Susceptibility Testing Using Commercial Agar Dilution Test.使用商业琼脂稀释试验进行磷霉素药敏试验。
Microbiol Spectr. 2022 Apr 27;10(2):e0250421. doi: 10.1128/spectrum.02504-21. Epub 2022 Mar 30.
6
In vitro activity of fosfomycin against bacterial pathogens isolated from urine specimens in Canada from 2007 to 2020: CANWARD surveillance study.2007 年至 2020 年加拿大尿液分离菌的体外药敏研究:CANWARD 监测研究。
J Antimicrob Chemother. 2022 Oct 28;77(11):3035-3038. doi: 10.1093/jac/dkac275.
7
[Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations].[根据美国临床和实验室标准协会(CLSI)及欧洲抗菌药物敏感性试验委员会(EUCAST)建议,产超广谱β-内酰胺酶的尿源大肠埃希菌分离株对磷霉素的敏感性]
Mikrobiyol Bul. 2014 Oct;48(4):545-55.
8
[Sensitivity to fosfomycin of bacteria isolated at the Pitié-Salpétrière Hospital in 1982 and 1983].[1982年和1983年在皮提耶尔-萨尔佩特里埃医院分离出的细菌对磷霉素的敏感性]
Pathol Biol (Paris). 1984 Jun;32(5 Pt 2):520-4.
9
Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates.磷霉素活性及几种药敏试验方法对当代尿液分离株的比较。
Int J Antimicrob Agents. 2015 Dec;46(6):642-7. doi: 10.1016/j.ijantimicag.2015.08.012. Epub 2015 Sep 30.
10
Fosfomycin susceptibility in carbapenem-resistant Enterobacteriaceae from Germany.德国耐碳青霉烯类肠杆菌科细菌对磷霉素的敏感性
J Clin Microbiol. 2014 Jun;52(6):1893-7. doi: 10.1128/JCM.03484-13. Epub 2014 Mar 19.

引用本文的文献

1
Epoxy-Functionalized Isatin Derivative: Synthesis, Computational Evaluation, and Antibacterial Analysis.环氧官能化异吲哚酮衍生物:合成、计算评估及抗菌分析
Antibiotics (Basel). 2025 Jun 9;14(6):595. doi: 10.3390/antibiotics14060595.
2
Antimicrobial susceptibilities of clinical bacterial isolates from urinary tract infections to fosfomycin and comparator antibiotics determined by agar dilution method and automated micro broth dilution.采用琼脂稀释法和自动微量肉汤稀释法测定尿路感染临床分离菌株对磷霉素及对照抗生素的药敏情况。
Microbiol Spectr. 2025 Mar 4;13(3):e0186024. doi: 10.1128/spectrum.01860-24. Epub 2025 Feb 5.
3
High prevalence of antimicrobial resistance genes in multidrug-resistant-ESBLs-producing post-COVID-19 pandemic.新冠疫情后产超广谱β-内酰胺酶多重耐药菌中抗菌药物耐药基因的高流行率
Iran J Microbiol. 2024 Dec;16(6):745-754. doi: 10.18502/ijm.v16i6.17247.
4
Antimicrobial Regimens in Cement Spacers for Periprosthetic Joint Infections: A Critical Review.用于人工关节周围感染的骨水泥间隔物中的抗菌方案:一项批判性综述。
Antibiotics (Basel). 2024 Aug 15;13(8):772. doi: 10.3390/antibiotics13080772.
5
Biocompatible antibiotic-coupled nickel-titanium nanoparticles as a potential coating material for biomedical devices.生物相容性抗生素偶联镍钛纳米颗粒作为生物医学装置的潜在涂层材料。
Heliyon. 2024 May 18;10(10):e31434. doi: 10.1016/j.heliyon.2024.e31434. eCollection 2024 May 30.
6
Fosfomycin susceptibility testing and resistance mechanisms in Enterobacterales in South Africa.南非肠杆菌科细菌中磷霉素药敏试验及耐药机制
Afr J Lab Med. 2024 Mar 19;13(1):2252. doi: 10.4102/ajlm.v13i1.2252. eCollection 2024.
7
Antibiotic Resistance to Molecules Commonly Prescribed for the Treatment of Antibiotic-Resistant Gram-Positive Pathogens: What Is Relevant for the Clinician?对常用于治疗耐抗生素革兰氏阳性病原体的分子的抗生素耐药性:临床医生应关注什么?
Pathogens. 2024 Jan 19;13(1):88. doi: 10.3390/pathogens13010088.
8
Intravenous Fosfomycin for Systemic Multidrug-Resistant Infections.静脉注射磷霉素治疗全身性多重耐药感染
Antibiotics (Basel). 2023 Nov 23;12(12):1653. doi: 10.3390/antibiotics12121653.
9
Self-isolation of an Italian long-term care facility during COVID-19 pandemic: A comparison study on care-related infectious episodes.COVID-19大流行期间一家意大利长期护理机构的自我隔离:护理相关感染事件的比较研究
Open Med (Wars). 2023 Oct 27;18(1):20230822. doi: 10.1515/med-2023-0822. eCollection 2023.
10
activities of antimicrobial combinations against planktonic and biofilm forms of .抗菌组合对浮游菌和生物被膜形式的活性。 (原文句子似乎不完整,缺少具体针对的菌种等信息)
Front Microbiol. 2023 Jun 20;14:1186669. doi: 10.3389/fmicb.2023.1186669. eCollection 2023.

本文引用的文献

1
Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes.日本产 CTX-M 型大肠埃希菌临床分离株中磷霉素耐药的流行情况及新型质粒介导的磷霉素修饰酶的鉴定。
Antimicrob Agents Chemother. 2010 Jul;54(7):3061-4. doi: 10.1128/AAC.01834-09. Epub 2010 Apr 19.
2
In vitro fosfomycin activity in vancomycin-resistant Enterococcus faecalis.万古霉素耐药粪肠球菌的体外磷霉素活性。
Braz J Infect Dis. 2009 Apr;13(2):123-4. doi: 10.1590/s1413-86702009000200010.
3
Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin.多药耐药(MDR)和广泛耐药(XDR)肠杆菌科分离株对磷霉素的药敏性。
Int J Antimicrob Agents. 2010 Mar;35(3):240-3. doi: 10.1016/j.ijantimicag.2009.10.019.
4
In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin.磷霉素对含 blaKPC 肺炎克雷伯菌分离株的体外活性研究,包括那些对替加环素和/或多粘菌素不敏感的分离株。
Antimicrob Agents Chemother. 2010 Jan;54(1):526-9. doi: 10.1128/AAC.01235-09. Epub 2009 Nov 9.
5
Susceptibility of urinary tract bacteria to fosfomycin.尿路细菌对磷霉素的敏感性。
Antimicrob Agents Chemother. 2009 Oct;53(10):4508-10. doi: 10.1128/AAC.00721-09. Epub 2009 Aug 17.
6
Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies.磷霉素治疗具有先进抗微生物药物耐药性的革兰阳性球菌引起的感染:微生物学、动物和临床研究综述。
Expert Opin Investig Drugs. 2009 Jul;18(7):921-44. doi: 10.1517/13543780902967624.
7
Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies.磷霉素用于治疗多重耐药非发酵革兰氏阴性杆菌引起的感染:微生物学、动物和临床研究的系统评价
Int J Antimicrob Agents. 2009 Aug;34(2):111-20. doi: 10.1016/j.ijantimicag.2009.03.009. Epub 2009 Apr 28.
8
Therapeutic options for infections due to vancomycin-resistant enterococci.耐万古霉素肠球菌感染的治疗选择
Expert Opin Pharmacother. 2009 Apr;10(5):785-96. doi: 10.1517/14656560902811811.
9
Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.产超广谱β-内酰胺酶大肠埃希菌引起的社区感染
Arch Intern Med. 2008 Sep 22;168(17):1897-902. doi: 10.1001/archinte.168.17.1897.
10
Fosfomycin: use beyond urinary tract and gastrointestinal infections.磷霉素:在泌尿道和胃肠道感染之外的应用。
Clin Infect Dis. 2008 Apr 1;46(7):1069-77. doi: 10.1086/527442.

琼脂稀释法和纸片扩散法测定常见细菌分离株对磷霉素的药敏性。

Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomycin determined by agar dilution and disk diffusion methods.

机构信息

Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, Hsin-Chu, Taiwan.

出版信息

Antimicrob Agents Chemother. 2011 Sep;55(9):4295-301. doi: 10.1128/AAC.00349-11. Epub 2011 Jun 13.

DOI:10.1128/AAC.00349-11
PMID:21670185
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3165352/
Abstract

We studied the antimicrobial activity of fosfomycin against 960 strains of commonly encountered bacteria associated with urinary tract infection using standard agar dilution and disk diffusion methods. Species studied included 3 common species of Enterobacteriaceae, Pseudomonas aeruginosa, Acinetobacter baumannii, and Stenotrophomonas maltophilia; methicillin-susceptible and -resistant Staphylococcus aureus; and vancomycin-susceptible and resistant Enterococcus faecalis and E. faecium. MICs and inhibition zone diameters were interpreted in accordance with both the currently recommended Clinical and Laboratory Standards Institute (CLSI) criteria for urinary tract isolates of Escherichia coli and Enterococcus faecalis and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) criteria for Enterobacteriaceae. Tentative zone diameter interpretive criteria were developed for species not currently published by CLSI or EUCAST. Escherichia coli was uniformly susceptible to fosfomycin, as were most strains of Klebsiella pneumoniae and Enterobacter cloacae. A. baumannii was resistant to fosfomycin, while the prevalence of resistance in P. aeruginosa and S. maltophilia was greatly affected by the choice of MIC breakpoint. New tentative zone diameter criteria for K. pneumoniae, E. cloacae, S. aureus, and E. faecium were able to be set, providing some interim laboratory guidance for disk diffusion until further breakpoint evaluations are undertaken by CLSI and EUCAST.

摘要

我们使用标准琼脂稀释和纸片扩散法研究了磷霉素对 960 株常见尿路感染相关细菌的抗菌活性。研究的菌种包括 3 种常见的肠杆菌科细菌、铜绿假单胞菌、鲍曼不动杆菌和嗜麦芽窄食单胞菌;耐甲氧西林和甲氧西林敏感的金黄色葡萄球菌;以及对万古霉素敏感和耐药的粪肠球菌和屎肠球菌。MIC 和抑菌圈直径的解释均符合目前推荐的 CLSI 标准,用于解释尿路感染的大肠埃希菌和粪肠球菌分离株,以及用于肠杆菌科的欧洲抗菌药物敏感性测试委员会(EUCAST)标准。对于 CLSI 或 EUCAST 尚未公布的菌种,制定了暂定的抑菌圈直径解释标准。大肠杆菌对磷霉素普遍敏感,大多数肺炎克雷伯菌和阴沟肠杆菌菌株也是如此。鲍曼不动杆菌对磷霉素耐药,而铜绿假单胞菌和嗜麦芽窄食单胞菌的耐药率则受到 MIC 折点选择的极大影响。能够为肺炎克雷伯菌、阴沟肠杆菌、金黄色葡萄球菌和屎肠球菌设定新的暂定抑菌圈直径标准,为纸片扩散法提供了一些临时的实验室指导,直至 CLSI 和 EUCAST 进一步评估折点。